Article Link: https://www.axios.com/2024/02/21/til-cancer-treatment-cell-therapy-iovance-fda
Part 2: How T Cell Activation Redefines TIL and CAR-T Manufacturing (Boosting Success Rates to 95%) with Chantale Bernatchez
When every batch belongs to a single patient, a single centralized facility cannot serve the world. In Part 2, Chantale Bernatchez moves from...